T1	Participants 74 87	osteoporosis?
T2	Participants 478 600	Consecutive post-menopausal women aged 50 years to 86 years starting treatment with raloxifene according to daily practice
T3	Participants 606 654	enrolled from 126 primary care offices in Spain.
T4	Participants 942 967	745 post-menopausal women
T5	Participants 1001 1029	with a mean age of 62 years,